Abstract
We used a spin-labeled ATP analog, SL-ATP, to study nucleotide binding to highly purified human multidrug resistance protein 3, MRP3, which had been expressed in the yeast Pichia pastoris. SL-ATP was shown to be a good substrate analog and is hydrolyzed by MRP3 at about 10% of the Vmax for normal ATP. ESR titrations showed that 2 mol of SL-ATP readily bound per mole of MRP3 with a dissociation constant of about 100 μM in the presence of Mg2+ ions. The binding curve was easily fitted for a hyperbolic binding relationship. SL-ATP also bound readily to MRP3 in the absence of divalent ions and presence of EDTA. The resulting binding curve, however, could not be satisfactorily fitted using the equation for hyperbola. Analysis showed that a good fit was only obtained with the Hill equation using a Hill coefficient of 4 or close to 4. Lower Hill coefficients resulted in lower goodness of the fit. Such cooperative binding may be explained by a dimerization event triggered in the absence of divalent ions and a close communication of nucleotide binding sites of the interacting dimers. These findings may be of great importance for the overall mechanism and regulation of multidrug resistance proteins.
Similar content being viewed by others
References
Aleksandrov L, Aleksandrov AA, Chang X, Riordan JR (2002) J Biol Chem 277:15419–15425
Aleksandrov L, Mengos A, Chang X, Aleksandrov A, Riordan JR (2001) J Biol Chem 276:12918–12923
Basso C, Vergani P, Nairn AC, Gadsby DC (2003) J Gen Physiol 122:333–348
Bodó A, Bakos E, Szeri F, Váradi A, Sarkadi B (2003) Toxicol Lett 140–141:133–143
Burgard S, Harada M, Kagawa Y, Trommer WE, Vogel PD (2003) Cell Biochem Biophys 39:175–181
Burgard S, Nett JH, Sauer HE, Kagawa Y, Schäfer HJ, Wise JG, Vogel PD, Trommer WE (1994) J Biol Chem 269:17815–17819
Chloupková M, Pickert A, Lee J, Souza S, Trinh YT, Connelly SM, Dumont ME, Dean M, Urbatsch IL (2007) Biochemistry 46:7992–8003
Chu X, Huskey SW, Braun MP, Sarkadi B, Evans DC, Evers R (2004) J Pharmacol Exp Ther 309:156–164
Delannoy S, Urbatsch IL, Tombline G, Senior AE, Vogel PD (2005) Biochemistry 44:14010–14019
Dias JM, Szegedi C, Jóna I, Vogel PD (2006) Biochemistry 45:9408–9415
Gao M, Cui HR, Loe DW, Grant CE, Almquist KC, Cole SP, Deeley RG (2000) J Biol Chem 275:13098–13108
Haller M, Hoffmann U, Schanding T, Goody RS, Vogel PD (1997) J Biol Chem 272:30103–30107
Hirohashi T, Suzuki H, Sugiyama Y (1999) J Biol Chem 274:15181–15185
Hou Y, Cui L, Riordan JR, Chang X (2000) J Biol Chem 275:20280–20287
Hou Y, Cui L, Riordan JR, Chang X (2002) J Biol Chem 277:5110–5119
Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P (1997) Cancer Res 57:3537–3547
Kruh GD, Zeng H, Rea PA, Liu G, Chen ZS, Lee K, Belinsky MG (2001) J Bioenerg Biomembr 33:493–501
Lerner-Marmarosh N, Gimi K, Urbatsch IL, Gros P, Senior AE (1999) J Biol Chem 274:34711–34718
Lösel RM, Erbse AH, Nett JH, Wise JG, Berger G, Girault G, Vogel PD (1996) Spectrochimica Acta Part A 52:73–83
Lösel RM, Wise JG, Vogel PD (1997) Biochemistry 36:1188–1193
Neuhofen S, Theyssen H, Reinstein J, Trommer WE, Vogel PD (1996) Eur J Biochem 240:78–82
Renes J, de Vries EGE, Jansen PLM, Müller M (2000) Drug Resist Updat 3:289–302
Scheibel T, Neuhofen S, Weikl T, Mayr C, Reinstein J, Vogel PD, Buchner J (1997) J Biol Chem 272:18608–18613
Van Aubel RA, Masereeuw R, Russel FG (2000) Am J Physiol Renal Physiol 279:F216–F232
Van Veldhoven PP, Mannaerts GP (1987) Anal Biochem 161:45–48
Vogel G, Steinhart R (1976) Biochemistry 15:208–216
Vogel PD, Nett JH, Sauer HE, Schmadel K, Cross RL, Trommer WE (1992) J Biol Chem 267:11982–11986
Zehnpfennig B, Urbatsch IL, Galla H (2009) Biochemistry 48:4423–4430
Zelcer N, Saeki T, Reid G, Beijnen JH, Borst P (2001) J Biol Chem 276:46400–46407
Zelcer N, van de Wetering K, Hillebrand M, Sarton E, Kuil A, Wielinga PR, Tephly T, Dahan A, Beijnen JH, Borst P (2005) Proc Natl Acad Sci USA 102:7274–7279
Acknowledgments
This work was supported by a grant from the SMU University Research Council to PDV and a grant from the Jasper and Jack Wilson Foundation to ILU. The authors wish to thank J. G. Wise for helpful discussions. The authors wish to thank Dr. Jürgen Zirkel, Lipoid GmbH, Germany, for providing us with 100% pure lyso-phosphatidyl cholin.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoffman, A.D., Urbatsch, I.L. & Vogel, P.D. Nucleotide Binding to the Human Multidrug Resistance Protein 3, MRP3. Protein J 29, 373–379 (2010). https://doi.org/10.1007/s10930-010-9262-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-010-9262-4